Top

Osteoporosis International

Published in:

01-01-2013 | Letter

Pitfalls in the external validation of FRAX: response to Bolland et al.

Authors: J. A. Kanis, A. Oden, H. Johansson, E. McCloskey

Published in: Osteoporosis International | Issue 1/2013

Excerpt

Dear Editor, …

Kanis JA, Oden A, Johansson H, McCloskey E (2012) Pitfalls in the external validation of FRAX. Osteoporos Int 23:423–431. doi:10.1007/s00198-011-1846-0 PubMedCrossRef

Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. Available at http://www.shef.ac.uk/FRAX/index.htm

Collins GS, Mallett S, Altman DG (2011) Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFracture Scores. BMJ 342:d3651. doi:10.1136/bmj.d3651 PubMedCrossRef

Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRef

Bolland MJ, Siu AT, Mason BH et al (2011) Evaluation of the FRAX and Garvan fracture risk calculators in older women. J Bone Miner Res 26:420–427PubMedCrossRef

Kanis JA, Hans D, Cooper C et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:395–411

Title: Pitfalls in the external validation of FRAX: response to Bolland et al.
Authors: J. A. Kanis
A. Oden
H. Johansson
E. McCloskey
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 1/2013
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-012-1985-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Pitfalls in the external validation of FRAX: response to Bolland et al.

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients

Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women

The effect of treatments for osteoporosis on mortality

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis